Lataa...

Run-In Phase III Trial Design With Pharmacodynamics Predictive Biomarkers

BACKGROUND: Developments in biotechnology have stimulated the use of predictive biomarkers to identify patients who are likely to benefit from a targeted therapy. Several randomized phase III designs have been introduced for development of a targeted therapy using a diagnostic test. Most such design...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hong, Fangxin, Simon, Richard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888165/
https://ncbi.nlm.nih.gov/pubmed/24096624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt265
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!